» Articles » PMID: 38561768

Cancer-derived Exosomes As Novel Biomarkers in Metastatic Gastrointestinal Cancer

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2024 Apr 2
PMID 38561768
Authors
Affiliations
Soon will be listed here.
Abstract

Gastrointestinal cancer (GIC) is the most prevalent and highly metastatic malignant tumor and has a significant impact on mortality rates. Nevertheless, the swift advancement of contemporary technology has not seamlessly aligned with the evolution of detection methodologies, resulting in a deficit of innovative and efficient clinical assays for GIC. Given that exosomes are preferentially released by a myriad of cellular entities, predominantly originating from neoplastic cells, this confers exosomes with a composition enriched in cancer-specific constituents. Furthermore, exosomes exhibit ubiquitous presence across diverse biological fluids, endowing them with the inherent advantages of non-invasiveness, real-time monitoring, and tumor specificity. The unparalleled advantages inherent in exosomes render them as an ideal liquid biopsy biomarker for early diagnosis, prognosticating the potential development of GIC metastasis.In this review, we summarized the latest research progress and possible potential targets on cancer-derived exosomes (CDEs) in GIC with an emphasis on the mechanisms of exosome promoting cancer metastasis, highlighting the potential roles of CDEs as the biomarker and treatment in metastatic GIC.

Citing Articles

Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma.

Chen X, Song F, Xiao P, Yao Y, Li D, Fang Y BMC Cancer. 2025; 25(1):402.

PMID: 40045286 PMC: 11884143. DOI: 10.1186/s12885-025-13820-x.


Exosomes and their distinct integrins transfer the characteristics of oxaliplatin- and 5-FU-resistant behaviors in colorectal cancer cells.

Vakili-Ghartavol Z, Deli H, Shadboorestan A, Sahebnasagh R, Motevaseli E, Ghahremani M Mol Med. 2025; 31(1):49.

PMID: 39915745 PMC: 11803997. DOI: 10.1186/s10020-025-01110-y.


A colorimetric nano-enzyme assay with Ni@Pt nanoparticles as signal labels for rapid and sensitive detection of exosomal Aβ42 in plasma.

Zhang J, Zhao Y, Hu H, Lv M, Zhang H Mikrochim Acta. 2025; 192(1):53.

PMID: 39753867 DOI: 10.1007/s00604-024-06862-8.


Research Progress of in the Treatment of Gastrointestinal Cancer.

Wang L, Ni B, Wang J, Zhou J, Wang J, Jiang J Integr Cancer Ther. 2024; 23:15347354241302049.

PMID: 39610320 PMC: 11605761. DOI: 10.1177/15347354241302049.


Exploring exosomes: novel diagnostic and therapeutic frontiers in thyroid cancer.

Zhang S, Yang Y, Wang D, Yang X, Cai Y, Shui C Front Pharmacol. 2024; 15:1431581.

PMID: 39584141 PMC: 11581896. DOI: 10.3389/fphar.2024.1431581.


References
1.
Huang C, Tang S, Shen D, Li X, Liang L, Ding Y . Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma. Oncol Lett. 2021; 21(2):168. PMC: 7798106. DOI: 10.3892/ol.2021.12429. View

2.
Zhu M, Zhang N, He S, Lu X . Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Cell Cycle. 2020; 19(10):1200-1221. PMC: 7217357. DOI: 10.1080/15384101.2020.1749467. View

3.
Sento S, Sasabe E, Yamamoto T . Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes. PLoS One. 2016; 11(2):e0148454. PMC: 4743844. DOI: 10.1371/journal.pone.0148454. View

4.
Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y . Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023; 22(1):55. PMC: 10024440. DOI: 10.1186/s12943-023-01759-1. View

5.
Tang P, Tao L, Yuan C, Zhang L, Xiu D . Serum Derived Exosomes From Pancreatic Cancer Patients Promoted Metastasis: An iTRAQ-Based Proteomic Analysis. Onco Targets Ther. 2019; 12:9329-9339. PMC: 6844101. DOI: 10.2147/OTT.S229494. View